Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 24.29M $4.49B Dec. 31, 2014
T. Rowe Price Associates 20.18M $3.73B Dec. 31, 2014
FMR 20.10M $3.33B Sept. 30, 2014
Vanguard 10.66M $1.97B Dec. 31, 2014
STATE STREET CORPORATION 8.56M $1.58B Dec. 31, 2014
JPMORGAN CHASE & CO 6.54M $1.21B Dec. 31, 2014
Jennison Associates 5.79M $1.07B Dec. 31, 2014
Sands Capital Management 5.27M $974.72M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 5.11M $945.29M Dec. 31, 2014
Wells Fargo & Company 4.40M $813.46M Dec. 31, 2014
Columbia Wanger Asset Management 3.71M $344.78M March 31, 2012
BlackRock Fund Advisors 3.58M $663.19M Dec. 31, 2014
VIKING GLOBAL INVESTORS 3.45M $401.29M Sept. 30, 2013
WINSLOW CAPITAL MANAGEMENT INC /MN 3.35M $619.67M Dec. 31, 2014
Inves 3.35M $555.31M Sept. 30, 2014
American Century Companies 3.26M $539.86M Sept. 30, 2014

Who sold Alexion Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ameriprise Financial June 30, 2011 6.24M $293.38M